INT341426

Context Info Confidence 0.51 First Reported 2010 Last Reported 2010 Negated 0 Speculated 1 Reported most in Body Documents 1 Total Number 1 Disease Relevance 0.50 Pain Relevance 0.47

signal transduction (EPO, NGF) extracellular space (EPO, NGF) extracellular region (EPO, NGF) endosome (NGF) aging (EPO)

Anatomy Link Frequency blood 1 EPO (Homo sapiens) NGF (Homo sapiens)

Pain Link Frequency Relevance Heat Nerve growth factor 3 100.00 Inflammatory marker 2 99.80 antidepressant 24 97.96 Inflammation 2 93.64 Hippocampus 2 79.76 imagery 6 75.48 depression 24 50.00 Multiple sclerosis 2 5.00 Spinal cord 1 5.00 ischemia 1 5.00

Disease Link Frequency Relevance Heat INFLAMMATION 4 99.80 Obesity 1 75.28 Affective Disorder 15 66.72 Cognitive Disorder 26 61.08 Disorder Of Lipid Metabolism 1 55.20 Attention Deficit Hyperactivity Disorder 7 52.72 Depression 22 50.00 Manic Depressive Disorder 16 5.00 Aplasia 6 5.00 Hypertension 4 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

We will therefore investigate the effect of Epo on plasma and whole blood BDNF, NGF and inflammatory markers incl. interleukin-6 (IL-6) and C-reactive protein (CRP).

Epo Spec (investigate) Regulation (effect) of NGF in blood associated with nerve growth factor and inflammatory marker

1) Confidence 0.51 Published 2010 Journal Trials Section Body Doc Link PMC2967509 Disease Relevance 0.50 Pain Relevance 0.47

General Comments

This test has worked.